申请人:Aronex Pharmaceuticals, Inc.
公开号:US05994321A1
公开(公告)日:1999-11-30
A series of guanine analogs and physiological salts thereof, which are useful as virus inhibitors and as antiviral agents in the treatment of viral disease, having the basic structures of: ##STR1## wherein B is H, CH.sub.3 or NH.sub.2 ; C is NH.sub.2 or SCH.sub.3 ; D is N or CH; E is O, S or Se; and G is selected from a group consisting of alkanes, alkenes, ethers, esters, hydrocarbons, amines and heterocyclic compounds, is herein disclosed. In I and III, A is O, S or Se while in II, A is NH.sub.2, OH, NHOH, OCH.sub.3 or SCH.sub.3. In I and II, F is 0, S or Se, while in III, F is F is 0, S, Se or NH. These compounds may be formulated with a physiological carrier, and used either alone or in combination with, for example, acyclovir or ganciclovir or another therapeutic agent, for the treatment of conditions resulting from viral infections.
本文披露了一系列鸟嘌呤类似物及其生理盐,其可用作病毒抑制剂和抗病毒剂,用于治疗病毒性疾病,具有以下基本结构:##STR1## 其中,B为H,CH.sub.3或NH.sub.2;C为NH.sub.2或SCH.sub.3;D为N或CH;E为O,S或Se;G从烷烃,烯烃,醚,酯,烃,胺和杂环化合物组成的群体中选择。在I和III中,A为O,S或Se,而在II中,A为NH.sub.2,OH,NHOH,OCH.sub.3或SCH.sub.3。在I和II中,F为0,S或Se,而在III中,F为0,S,Se或NH。这些化合物可以与生理载体配制,并单独使用或与其他治疗剂(例如阿昔洛韦或甘西韦)联合使用,用于治疗病毒感染引起的疾病。